Workflow
减肥
icon
Search documents
号称十天瘦十斤的“减肥神药”实则有毒,别被忽悠了!
Yang Shi Xin Wen· 2025-05-26 16:12
对于关注减肥话题的人群来说,现在市面上的各种减肥产品让人眼花缭乱。南京的周女士就关注到网络平台上的一款减肥药,这款减肥药声称"无需运动节 食、十天瘦十斤、明星都在吃、安全不反弹"。周女士被商家的宣传打动,当即下了单,但接下来的经历让她一言难尽。 五颜六色小药片 引发头晕失眠等多种反应 采用微商代理方式 超13万粒产品被查获 这就是令周女士心动的五颜六色小药片,因为减肥心切,她未加思索就加了客服的微信,并且毫不犹豫地付了款。 随后,周女士就收到了这些五颜六色大小不一的药片和胶囊,用透明的塑料袋分装成小包,每一包就是一天的服用量,疗程是30天。这些药没有生产厂家、 生产地址以及成分说明,更没有使用说明。刚开始服药的三天,周女士并没有觉得有什么异常,渐渐地她开始出现口渴口干、无精打采、心慌恶心甚至失眠 的症状。 服药十天以后,周女士确实感觉自己瘦了,但是头晕、烦躁、失眠等不良反应接踵而至,身体和精神状态一落千丈。她在家人的劝说下报了警。 检测发现减肥药竟含多种有毒有害成分 公安机关等相关部门立刻展开调查,他们把周女士提供的减肥药送到市场监管部门进行检测,检测的结果显示,这些减肥产品中含有麻黄碱、伪麻黄碱、芬 特拉明 ...
使用司美格鲁肽,不想反弹?掌握这些关键点很重要!
GLP1减重宝典· 2025-05-25 04:42
Core Viewpoint - Obesity is a health condition associated with excess fat accumulation, leading to various complications and comorbidities. GLP-1 receptor agonists have been developed and approved for obesity treatment, demonstrating effectiveness in appetite reduction and weight loss [1][2][4]. Summary by Sections Treatment Efficacy - GLP-1 receptor agonists, such as semaglutide and tirzepatide, have shown weight loss of 15%-20% after 68 to 72 weeks compared to placebo [2]. - A clinical trial indicated that participants lost an average of 10.6% of their body weight during 20 weeks of semaglutide treatment, with those continuing the drug losing an additional 7.9% over 48 weeks [5]. Challenges in Weight Maintenance - One of the biggest challenges in weight loss is maintaining the results, as many individuals experience weight regain after stopping treatment. Studies show that stopping GLP-1 receptor agonists can lead to significant weight gain [4][5]. - After one year of stopping semaglutide, approximately two-thirds of the weight lost can be regained [5]. Medication Management - It is recommended to continue GLP-1 receptor agonist treatment for at least 12 weeks to see significant effects, with a suggested continuation of 9 months to 1 year for consolidation [6]. - Users may experience increased satiety and reduced food intake initially, with weight loss typically ranging from 0.5 to 2 pounds per week [9]. Discontinuation Strategies - Gradual dose reduction is advised when stopping the medication to mitigate increased hunger, with specific recommendations for both non-diabetic and diabetic patients [10][12]. - Maintaining healthy eating habits and regular exercise is crucial post-discontinuation to prevent weight rebound [12]. Dietary and Lifestyle Recommendations - Key strategies to prevent weight regain include altering dietary habits by reducing high-calorie foods and increasing protein and fiber intake [13]. - Incorporating strength training and ensuring adequate sleep (7-9 hours per night) are also essential for maintaining weight loss and improving metabolic health [15].
饭后刷牙、减油、用蓝色餐具……记住这6条减肥冷知识帮你减肥
Bei Ke Cai Jing· 2025-05-19 10:31
日本一项研究调查发现,每天刷牙三次或三次以上的人更少出现肥胖问题。专家认为,刷牙会让口腔有 一种清新干净的感觉,这种感觉会在一定程度上抑制再次进食的欲望,从而更好地管理体重。 3.用对餐具瘦得快 研究发现,蓝色餐具可以使人们的食欲降低40%。看到蓝色食物时,人们很难立刻联想到食物,从而减 少了进食欲望。此外还有研究发现,使用小号碗盘可以使进食量减少15%,单顿热量能减少20%。 4.减肥要"多"吃 肥胖也属于"营养不良",80%的胖友体内至少缺两种营养素。减肥更要注意营养的均衡和食物的多样 化:多吃全谷物、杂豆和薯类食物;多吃蔬菜水果;多喝水以促进代谢并减少饥饿感。 5月20日是2025年全民营养周暨中国学生营养日,今年的主题是"吃动平衡 健康体重 全民行动"。肥胖问 题在近年来愈发凸显,给患者本身和国家医疗体系都带来了巨大压力。国家卫生健康委等16个部委在 2024年联合启动了为期三年的"体重管理年"行动,将肥胖防控提升到国家战略高度。 "体重管理"火速出圈,各大医院开设体重管理的相关门诊,体重门诊爆满等话题也频上热搜。当"国家 喊你减肥"成为现实命题,减肥却陷入困局,很多人对于如何减肥依然存在认知误区。为 ...
以为会变胖,实际很减肥!这5个习惯,你中了几个?
Yang Shi Xin Wen· 2025-05-18 02:15
Group 1 - The core idea emphasizes the importance of post-exercise nutrition for weight loss and muscle gain, highlighting that a high-protein diet after exercise can lead to a BMI reduction of 0.6 points, equivalent to approximately 3.5 pounds for a 1.7-meter tall adult [2] - Consuming carbohydrates post-exercise helps replenish glycogen stores and prevents muscle breakdown, while protein stimulates muscle protein synthesis, aiding in recovery and growth [4] - A combination of carbohydrates and protein optimizes recovery, significantly increasing glycogen synthesis efficiency [4] Group 2 - Sufficient carbohydrate intake generally does not lead to excessive fat production, with studies indicating that only 1% to 2% of excess carbohydrates are converted to fat [5] - Carbohydrates help stabilize appetite and prevent cravings, as they stimulate insulin secretion, which regulates appetite [6] - Adequate carbohydrate consumption promotes the secretion of FGF21, a hormone that aids in energy expenditure and fat reduction [8] Group 3 - Eating fruit before meals can help control calorie intake, with studies showing that consuming an apple before a meal can reduce caloric intake by approximately 187 kcal [9] - Eating fruit before meals can lower post-meal blood sugar responses, with research indicating that consuming kiwi before rice resulted in the best outcomes for blood sugar levels [9] - Following two guidelines for fruit consumption can enhance weight loss and blood sugar control: avoiding high-sugar fruits and choosing nutrient-dense options [11] Group 4 - A meta-analysis involving over 1,000 participants found that high-protein diets led to an average weight loss of 1.6 pounds and a reduction in fat mass by 1.74 pounds compared to conventional diets [13] - Adequate protein intake promotes long-lasting satiety by stimulating the release of CCK, a hormone that signals fullness to the brain [14] - Protein is essential for muscle repair and growth, helping to prevent fat accumulation and maintain a higher basal metabolic rate [15] Group 5 - Recommended protein sources for weight loss include fish, shrimp, and poultry, while red meats should be secondary choices [17] - When consuming meat, lean cuts should be prioritized, avoiding fatty parts and processed meats high in salt and fat [18] Group 6 - Research indicates that for overweight individuals, an additional hour of sleep can reduce caloric intake by approximately 270 kcal [19] - Two key practices for effective weight loss through sleep include going to bed early (between 10 PM and 11 PM) and maintaining a sleep duration of around 7 hours [19]
杨天真,瘦了107斤!
GLP1减重宝典· 2025-05-12 08:34
Core Viewpoint - The article discusses the weight loss journey of Yang Tianzhen, highlighting her recent physical transformation and the methods she employed, including exercise and dietary changes, while clarifying that her weight loss is not solely due to traditional dieting methods [4][8]. Group 1: Yang Tianzhen's Weight Loss Journey - Yang Tianzhen has recently shared her weight loss progress, showcasing her commitment to exercise, particularly badminton, which has resulted in visible muscle definition [2][7]. - Despite public admiration for her efforts, there are mixed reactions, with some questioning the authenticity of her weight loss and others noting her previous statements against dieting [4]. - Yang underwent gastric surgery five years ago to manage diabetes, emphasizing that her primary motivation for the surgery was health-related rather than weight loss [4][5]. Group 2: Celebrity Weight Loss Trends - The article notes a surge in weight loss stories among celebrities, with many utilizing medications like Semaglutide and Tirzepatide for weight management [9]. - Elon Musk reported a weight loss of 30 pounds (approximately 27.2 kg) using Semaglutide [9]. - Other celebrities, including Whoopi Goldberg and Kelly Clarkson, have also shared their experiences with weight loss medications, highlighting significant weight reductions [11][13]. Group 3: Efficacy of Semaglutide - Clinical trials (STEP series) indicate that Semaglutide can lead to an average weight loss of 15% to 18% in obese patients, significantly outperforming placebo groups [21][26]. - In the STEP 1 trial, participants lost an average of 14.9% of their body weight, with over one-third losing more than 20% [23]. - The FDA approved Semaglutide for long-term weight management in adults with obesity or overweight conditions in June 2021, marking it as a significant advancement in obesity treatment [26]. Group 4: Efficacy of Tirzepatide - The SURMOUNT studies demonstrate that Tirzepatide can achieve substantial weight loss, with participants losing up to 26.6% of their body weight over 72 weeks [31]. - In the SURMOUNT-2 trial, patients with type 2 diabetes lost an average of 15.7% of their body weight, showcasing the drug's effectiveness [29]. - The FDA approved Tirzepatide for obesity treatment based on its promising results in clinical trials [30].
用司美格鲁肽减重后停药,44%的人都后悔了!
GLP1减重宝典· 2025-05-12 04:32
Core Viewpoint - China has the highest number of overweight and obese individuals globally, with over half of the adult population affected, leading to significant health concerns and potential market opportunities for weight loss solutions [1][2]. Group 1: Obesity Statistics - As of 2021, 16.4% of adults in China are classified as obese, while 34.3% are overweight, totaling approximately 532 million individuals, with nearly 100 million being obese [1]. - A 2020 study predicts that by 2030, the number of overweight adults in China will reach 540 million, and the obese population will increase to 150 million, representing growth of 2.8 times and 7.5 times, respectively, since 2000 [1]. Group 2: Medication Usage and Compliance - Semaglutide, a GLP-1 receptor agonist, has transformed the weight loss market, but many users discontinue its use after a period [2]. - Research indicates that 44% of patients remain on semaglutide after three months, 33% after six months, and only 19% after one year. In contrast, 63%, 56%, and 40% of semaglutide users continue after three months, six months, and one year, respectively [4]. Group 3: Effects of Discontinuation - A clinical trial showed that participants lost an average of 10.6% of their body weight during 20 weeks of semaglutide treatment, but those who switched to a placebo regained an average of 6.9% of their weight, while those who continued with semaglutide lost an additional 7.9% [5]. - An observational study found that 18% of patients regained their lost weight after one year off semaglutide, with 26% regaining more than 25% of their lost weight, while 56% maintained or continued to lose weight [5]. Group 4: Reasons for Discontinuation - Common side effects of GLP-1RA drugs include nausea, diarrhea, and vomiting, which may lead to discontinuation. Even at low doses, 17% of patients reported nausea, with higher rates of gastrointestinal issues at increased doses [6]. - Supply issues have also contributed to discontinuation, as semaglutide has been in short supply since 2022 [7]. - Other reasons for stopping include reaching a weight loss plateau or achieving target weight [9][10]. Group 5: Recommendations for Discontinuation - Gradual dose reduction is recommended to minimize rebound hunger and maintain weight loss. Patients should monitor their appetite and weight closely after discontinuation [11][14]. - Maintaining a healthy lifestyle post-medication is crucial to prevent weight regain, as obesity is a chronic condition requiring ongoing management [22]. Group 6: Lifestyle Management - The latest Chinese weight loss guidelines emphasize lifestyle interventions, including dietary management, exercise, and behavioral changes, as essential for long-term weight management [15]. - Dietary management aims to reduce caloric intake while improving metabolic health, with various dietary patterns showing short-term weight loss effects [16][18]. - Exercise plays a significant role in maintaining weight loss and improving quality of life, despite only achieving modest weight reductions on its own [19]. - Behavioral management is critical for successful weight loss, with structured programs showing significant weight reduction in the initial months [20][21].
配料表越短=食品越健康?两码事!
Bei Jing Qing Nian Bao· 2025-05-12 00:57
Group 1 - The length of the ingredient list does not directly correlate with food safety, and shorter lists do not necessarily indicate healthier options [6][7][8] - Food safety is determined by the type and amount of additives used, rather than the number of additives present [7][9] - The concept of "zero preservatives" can be misleading, as preservatives play a crucial role in preventing food spoilage and ensuring safety [9][10] Group 2 - Sunlight exposure through glass does not effectively contribute to calcium absorption due to significant reduction in UVB penetration [2][3] - The optimal times for sunlight exposure to synthesize vitamin D are between 9-10 AM and 3-5 PM, with 30-60 minutes of exposure recommended [3] - Solar panels do not emit harmful electromagnetic radiation, and their operation is well within safety standards set by health organizations [4][5]
戒奶茶断甜品还不够,专家提醒减肥要注意“减油”
Bei Ke Cai Jing· 2025-05-10 02:44
科学减油,少用煎和炸 据估算,中国居民膳食中的脂肪摄入量一半都来源于烹调油,使用控油壶能帮助人们合理规划用油量; 建议选择大豆油、菜籽油、花生油、橄榄油、茶籽油、葵花籽油、色拉油等植物油烹饪,尽量避免使用 动物油;烹饪方法多用蒸、煮、白灼和凉拌等方式,少用煎和炸的方法;学会看预包装食品的营养标 签,选择脂肪含量少的食品。 点餐或叫外卖时要注意荤素搭配,以清淡口味菜品为主,尽量少点重口味菜品,可在备注里要求商家少 放盐、油、糖,也可以用白开水涮一涮再吃。 5月11日是第8个世界防治肥胖日。当体重秤上的数字持续攀升,很多人首先想到的是戒奶茶、断甜品, 却对餐桌上泛着油光的红烧肉和油汪汪的炒青菜视若无睹。中国疾病预防控制中心营养与健康所研究员 何丽指出,这种"超标摄油"现象绝非个例,减肥不能光盯着糖,还要注意减少油摄入。 长期忽视油脂控制或致肥胖 油,被忽视的肥胖元凶。过多摄入高能量、高脂肪的食物会增加超重和肥胖风险,还会破坏能量摄入与 消耗、脂肪合成与分解的平衡。研究发现,血液里的"坏胆固醇(低密度脂蛋白胆固醇)"每增加 1mmol/L,心脏血管堵塞风险就会上升近三成 ,这相当于在心脏的输油管道里不停堆积油垢。如 ...
哈佛大学医学院:除了减重降糖,司美格鲁肽还有这五大潜在益处
GLP1减重宝典· 2025-05-06 08:03
Core Viewpoint - The article discusses the benefits and mechanisms of GLP-1 receptor agonists, particularly focusing on their role in managing type 2 diabetes and supporting weight loss, highlighting their safety and potential cardiovascular benefits [1][3][5]. Summary by Sections GLP-1 Drug Mechanism - GLP-1 receptor agonists mimic the natural hormone GLP-1, which is released from the intestines after eating, enhancing insulin release, reducing appetite, and slowing gastric emptying [3]. - These drugs are administered via injection and are crucial for maintaining stable blood sugar levels in type 2 diabetes patients, thereby preventing long-term complications like cardiovascular diseases and kidney issues [3]. - Unlike insulin, GLP-1 drugs only lower blood sugar when levels are elevated, reducing the risk of hypoglycemia [3]. Weight Loss Support - GLP-1 receptor agonists are gaining attention for their weight loss effects, helping to suppress hunger and reduce calorie intake by delaying gastric emptying [5]. - When used specifically for weight loss, higher doses are typically administered compared to those used for diabetes treatment [5]. - Clinical trials indicate that users can lose 10% to 15% of their body weight within a year, with some achieving over 20% weight loss, significantly improving metabolic health and reducing risks of related diseases [5]. Emerging Benefits and Ongoing Research - Research is ongoing to explore the broader potential of GLP-1 drugs beyond diabetes management and weight loss, including: - Cardiovascular health: Some trials suggest reduced risks of heart attacks and strokes in obese or diabetic patients [6]. - Neuroprotection: Investigations into the role of GLP-1 in slowing cognitive decline and preventing Alzheimer's disease [6]. - Addiction treatment: Preliminary studies indicate potential benefits in reducing cravings for substances like nicotine and alcohol [6]. - Liver health: GLP-1 may help control metabolic liver diseases by reducing liver fat and inflammation [6]. - Sleep apnea: FDA approval for tirzepatide (Zepbound) for treating moderate to severe obstructive sleep apnea in obese adults is expected in December 2024 [6]. Common Side Effects - GLP-1 drugs may cause side effects, particularly gastrointestinal issues like nausea, vomiting, diarrhea, constipation, and abdominal discomfort, which often diminish as the body adjusts [7]. - Other less common reactions include dizziness, fatigue, increased heart rate, headaches, and mild irritation at injection sites [7]. - Continuous nausea or vomiting can lead to dehydration, malnutrition, or kidney problems, and these drugs are not suitable for individuals with severe digestive diseases or during pregnancy and breastfeeding [7][8]. Additional Health Concerns - Potential health issues associated with GLP-1 drugs include a small risk of pancreatitis, gallbladder problems, thyroid tumors (though no clear evidence in humans), and muscle loss due to rapid weight loss, particularly in older adults [8]. - Individuals considering GLP-1 treatment should discuss these risks with healthcare providers and may benefit from strategies to prevent muscle loss [8].
疯抢!“又贵又难吃”,价格猛涨4倍!此前一度卖不出去…
凤凰网财经· 2025-04-02 12:24
以下文章来源于21世纪经济报道 ,作者21记者 21世纪经济报道 . 权威、专业、深度、有趣!用经济思维看世界。 来源:21世纪经济报道 体重管理年减肥新招式频出,也有商家蹭起了热点。 近日,北京日报发布文章《又贵又难吃的羽衣甘蓝被疯抢》,质疑其健康价值,称部分品牌为改善口感添加糖分,可能变成高热量饮品。 热搜持续发酵, 话题#又贵又难吃的羽衣甘蓝被疯抢#一度登上微博热搜第一。 羽衣甘蓝能被包装成减肥利器,是多方合力的结果。羽衣甘蓝原产地位于地中海沿岸,其价值重塑过程始于原料本身的生物特性——这种十字花科植物确 实富含膳食纤维(每100克含量达3.6-4.1克)及维生素K、维生素C等微量元素,这种天然营养结构为后续营销提供了科学背书。 相关公开信息显示,羽衣甘蓝的膳食纤维吸水膨胀后能占据胃部空间,延缓胃排空,从而减少其他高热量食物的摄入,有助于控制体重,为它贴上"健康食 物"标签。 据相关资料显示,混果汁是国内最早将羽衣甘蓝应用于现制饮品的新茶饮品牌,而喜茶在2024年巴黎奥运会期间推出与安踏冠军联名的"夺冠纤体瓶",也 主打羽衣甘蓝成分。由于市场反响热烈,成功带动了其他品牌跟进,如奈雪的茶、茶百道、沪上阿姨 ...